Efficacy and Safety of Percutaneous Access Via Large-Bore Sheaths (22-26F Diameter) in Endovascular Therapy.
Bartosz RylskiZeynep BerkardaFriedhelm BeyersdorfStoyan KondovMartin CzernyJarosław MajcherekMarcin ProtasiewiczArtur MilnerowiczPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2023)
This study adds evidence on efficacy of accessing the artery via a large bore sheath (22-26F) secured by ProGlide. In more than 200 patients conversion to open surgery was necessary in only 4%. Severe femoral artery calcification was the sole risk factor for converting to open surgery. Our findings encourage physicians to choose the percutaneous access even in patients requiring the use of large bore sheath.
Keyphrases
- minimally invasive
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- stem cells
- coronary artery bypass
- coronary artery disease
- ultrasound guided
- mesenchymal stem cells
- patient reported
- cell therapy
- drug induced
- surgical site infection
- aortic dissection